Lingering for more than two years, the revamped 21st Century Cures bill, unveiled late Friday, now appears slated for House and Senate passage before President-elect Donald Trump takes office.

The 996-page bill includes major tweaks to the way in which the US Food and Drug Administration (FDA) regulates drugs, devices and biologics, while providing the agency with $500 million over 10 years to implement provisions that seek to move such products to patients more quickly, while maintaining the same standard for safety and effectiveness that the agency has adhered to in the past.